
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
This is a study of the commercial development of biotechnology which compares the initiatives, activities and organization of two firms--Genetech in the United States and Kabi in Sweden--as they brought knowledge to the market in the form of insulin and the human growth hormone. Writing from a broad evolutionary perspective, Maureen McKelvey's important study of one of the most modern science-based technologies will be of interest to all concerned with understanding the processes of innovation.
This book investigates the commercial development of biotechnology by analyzing how scientific knowledge is transformed into market-ready products. Maureen D. McKelvey, an expert in the economics of innovation, utilizes an evolutionary perspective to examine the organizational structures and strategic initiatives of firms operating within the science-based technology sector. By focusing on the specific trajectories of Genentech and Kabi, the author provides a framework for understanding how institutional environments influence the success of technological commercialization.
What You Will Find
Experts recognize this work as a significant contribution to the study of industrial organization and the economics of science. Readers frequently note the academic rigor of the text, which serves as a foundational resource for those analyzing the intersection of corporate strategy and scientific advancement.
Page Count:
336
Publication Date:
1996-07-25
Publisher:
Oxford University Press
ISBN-10:
0198289960
ISBN-13:
9780198289968
No comments yet. Be the first to share your thoughts!